Mundipharma International Limited
Unit 220
Cambridge Science Park<br>Milton Road
Cambridge
CB4 0GW
Tel: 44-1223-424211
Fax: 44-1223-426626
Website: http://www.mundipharma.co.uk/
14 articles about Mundipharma International Limited
-
Mundipharma and APR Applied Pharma Research Announce a New Alliance for the Distribution of Nexodyn AcidOxidizing Solution in Africa and the Levant
11/22/2017
Mundipharma will have exclusive rights to the product in more than 35 African markets and countries.
-
Mundipharma International Limited Release: Penthrox (Low Dose Methoxyflurane) Granted Marketing Authorization In France
6/21/2016
-
flutiform® Launched In Spain; Abriff® Launched In Italy SkyePharma Inc. To Receive €2 Million Milestone From Mundipharma International Limited
12/1/2014
-
Mundipharma International Limited's Commitment to Accelerated Business Growth Supported by Appointment of Paul Medeiros to Head its Corporate and Business Development
3/14/2012
-
Horizon Pharma, Inc. Enters Into Exclusive Agreement With Mundipharma International Limited for Commercialization of LODOTRA(R) (Modified-Release Prednisone) in Latin America
3/7/2012
-
Infinity Pharmaceuticals Inc. Gets $50 Million More in Mundipharma International Limited Deal
11/29/2011
-
Mundipharma International Limited Release: New Research Shows Chronic Pain is not Being Adequately Measured[1]
10/10/2011
-
Infinity Pharmaceuticals Inc. and Mundipharma International Limited Extend Global Strategic Alliance; Mundipharma Commits to Providing Up to $110 Million for 2012
12/13/2010
-
Infinity Pharmaceuticals Inc. Announces That Purdue Pharmaceutical Products L.P. and Mundipharma International Limited Exercise Rights to Develop and Commercialize Infinity's FAAH Pain Program Worldwide
10/26/2010
-
Mundipharma International Limited: Levact(R) (bendamustine) Recommended for Approval in Europe for Treating Blood Cancers
3/19/2010
-
Novelos Therapeutics, Inc. and Mundipharma International Limited Sign Exclusive Collaboration Agreement in Europe and Japan; Deal Potentially Worth $95 Million
2/12/2009
-
Infinity Pharmaceuticals, Inc. Announces Global Strategic Alliance With Purdue Pharmaceuticals L.P. and Mundipharma International Limited Encompassing Infinity's Early Clinical and Discovery Programs; Infinity to Receive Up to $75M Equity Investment, Acce
11/20/2008
-
Sosei Co., Ltd. Announces Agreement With Mundipharma International Limited For Ad 923
6/27/2006
-
Biocryst Pharmaceuticals And Mundipharma International Limited Collaborate On Development Of Fodosine(TM)
2/2/2006